Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' ADKINS D' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 68 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Khoury, H; Adkins, D; Brown, R; Pence, H; Vij, R; Goodnough, LT; Westervelt, P; Trinkaus, K; Lin, HS; DiPersio, J
      Low incidence of transplantation-related acute complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with a low-dose (550 cGy) total body irradiation conditioning regimen

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    2. Vij, R; DiPersio, J; Brown, R; Trinkaus, K; Abboud, C; Meehan, KR; Frenette, G; Freytes, C; Goodnough, LT; Khoury, H; Ponnuri, J; Adkins, D
      Outcomes of high-dose chemotherapy and autologous stem cell transplant in isolated locally recurrent breast cancer: a multicenter evaluation

      BONE MARROW TRANSPLANTATION
    3. Khoury, H; Adkins, D; Brown, R; Trinkaus, K; Vij, R; Miller, G; Goodnough, LT; DiPersio, J
      Does early treatment with high-dose methylprednisolone alter the course ofhepatic regimen-related toxicity?

      BONE MARROW TRANSPLANTATION
    4. Vij, R; Brown, R; Shenoy, S; Haug, JS; Kaesberg, D; Adkins, D; Goodnough, LT; Khoury, H; DiPersio, J
      Allogeneic peripheral blood stem cell transplantation following CD34(+) enrichment by density gradient separation

      BONE MARROW TRANSPLANTATION
    5. Khoury, H; Adkins, D; Brown, R; Vij, R; Westervelt, P; Trinkaus, K; Goodnough, LT; DiPersio, JF
      Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation

      BONE MARROW TRANSPLANTATION
    6. Adkins, D
      Granulocyte transfusions

      VOX SANGUINIS
    7. Spitzer, G; Meehan, K; Adkins, D
      High-dose therapy for primary and metastatic breast cancer

      HEMATOPOIETIC STEM CELL TRANSPLANTION
    8. Thornton, AC; Adkins, D; Arno, J
      Sexually transmitted diseases

      MANAGEMENT OF ANTIMICROBIALS IN INFECTIOUS DISEASES
    9. Adkins, D; Brown, R; Trinkaus, K; Maziarz, R; Luedke, S; Freytes, C; Needles, B; Wienski, D; Fracasso, P; Pluard, T; Moriconi, W; Ryan, T; Hoelzer, K; Safdar, S; Rearden, T; Rodriguez, G; Khoury, H; Vij, R; DiPersio, J
      Outcomes of high-dose chemotherapy and autologous stem-cell transplantation in stage IIIB inflammatory breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    10. Adkins, D; Brown, R; Goodnough, L; Khoury, H; DiPersio, J
      Purine analog regimens for allogeneic transplant?

      JOURNAL OF CLINICAL ONCOLOGY
    11. Brown, RA; Adkins, D; Khoury, H; Vij, R; Goodnough, LT; Shenoy, S; DiPersio, JF
      Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: Graft-versus-host disease and transplant-related mortality

      JOURNAL OF CLINICAL ONCOLOGY
    12. Naughton, M; Brown, R; Adkins, D; DiPersio, J
      Tularemia - an unusual cause of a solitary pulmonary nodule in the post-transplant setting

      BONE MARROW TRANSPLANTATION
    13. Khoury, H; Adkins, D; Brown, R; Goodnough, L; Gokden, M; Roberts, T; Storch, G; DiPersio, J
      Successful treatment of cerebral toxoplasmosis in a marrow transplant recipient: contribution of a PCR test in diagnosis and early detection

      BONE MARROW TRANSPLANTATION
    14. Bodo, I; Peters, M; Radich, JP; Hess, J; Blinder, M; Watson, MS; Van Rheeden, R; Natarajan, S; Lowell, JA; Brown, R; DiPersio, J; Adkins, D
      Donor-derived acute promyelocytic leukemia in a liver-transplant recipient

      NEW ENGLAND JOURNAL OF MEDICINE
    15. ADKINS D; JOHNSTON M; WALSH J; SPITZER G; GOODNOUGH T
      HYDROXYETHYLSTARCH SEDIMENTATION BY GRAVITY EX-VIVO FOR RED-CELL REDUCTION OF GRANULOCYTE APHERESIS COMPONENTS

      Journal of clinical apheresis
    16. KHOURY H; ADKINS D; ZEHNBAUER B; GOODNOUGH L; BROWN R; SAFDAR S; DIPERSIO JF
      ESSENTIAL THROMBOCYTHEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA

      Bone marrow transplantation
    17. ADKINS D; BROWN R; GOODNOUGH LT; KHOURY H; POPOVIC W; DIPERSIO J
      TREATMENT OF RESISTANT MANTLE CELL LYMPHOMA WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    18. ADKINS D; ALI S; DESPOTIS G; DYNIS M; GOODNOUGH LT
      GRANULOCYTE COLLECTION EFFICIENCY AND YIELD ARE ENHANCED BY THE USE OF A HIGHER INTERFACE OFFSET DURING APHERESIS OF DONORS GIVEN GRANULOCYTE-COLONY-STIMULATING FACTOR

      Transfusion
    19. BROWN RA; ADKINS D; GOODNOUGH LT; HAUG JS; TODD G; WEHDE M; HENDRICKS D; EHLENBECK C; LAUB L; DIPERSIO J
      FACTORS THAT INFLUENCE THE COLLECTION AND ENGRAFTMENT OF ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES

      Journal of clinical oncology
    20. GAJEWSKI J; WALL D; ADKINS D; GELLER R; YVER A; LLOYD K; SOUZA S; CHAMPLIN R
      A RANDOMIZED DOUBLE-BLIND TRIAL OF T-CELL DEPLETION WITH CD5 8 CELLECTOR(R) IN ADDITION TO CYCLOSPORINE, METHOTREXATE AND STEROIDS FOR ACUTE GRAFT-VERSUS-HOST DISEASE PREVENTION IN HLA MISMATCHED BONE-MARROW TRANSPLANT/

      Experimental hematology
    21. KHOURY H; ADKINS D; MILLER G; GOODNOUGH L; BROWN R; DIPERSIO J
      RESOLUTION OF INVASIVE CENTRAL-NERVOUS-SYSTEM ASPERGILLOSIS IN A TRANSPLANT RECIPIENT

      Bone marrow transplantation
    22. SPITZER G; ADKINS D; MATHEWS M; VELASQUEZ W; BOWERS C; DUNPHY F; KRONMUELLER N; NIEMEYER R; MCINTYRE W; PETRUSKA P
      RANDOMIZED COMPARISON OF G-CSF-CSF VS G-CSF ALONE FOR MOBILIZATION OFPERIPHERAL-BLOOD STEM-CELLS - EFFECTS ON HEMATOPOIETIC RECOVERY AFTERHIGH-DOSE CHEMOTHERAPY(GM)

      Bone marrow transplantation
    23. TSAI T; GOODMAN S; SAEZ R; SCHILLER G; ADKINS D; CALLANDER N; WOLFF S; FREYTES CO
      ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WHO RELAPSE AFTER AUTOLOGOUS TRANSPLANTATION

      Bone marrow transplantation
    24. ADKINS D; GOODGOLD H; HENDERSHOTT L; JOHNSTON M; CRAVENS D; SPITZER G
      INDIUM-LABELED WHITE BLOOD-CELLS APHERESED FROM DONORS RECEIVING G-CSF LOCALIZE TO SITES OF INFLAMMATION WHEN INFUSED INTO ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS

      Bone marrow transplantation
    25. FORD C; SPITZER G; REILLY W; ADKINS D
      A PHASE-II STUDY OF REPETITIVE CYCLES OF DOSE-INTENSE CARBOPLATIN PLUS PACLITAXEL CHEMOTHERAPY AND PERIPHERAL-BLOOD STEM-CELLS IN METASTATIC BREAST-CANCER

      Seminars in oncology
    26. ADKINS D; SPITZER G; JOHNSTON M; VELASQUEZ W; DUNPHY F; PETRUSKA P
      TRANSFUSIONS OF GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED GRANULOCYTE COMPONENTS TO ALLOGENEIC TRANSPLANT RECIPIENTS - ANALYSIS OF KINETICS AND FACTORS DETERMINING POSTTRANSFUSION NEUTROPHIL AND PLATELETCOUNTS

      Transfusion
    27. ADKINS D; GOODNOUGH LT; BROWN R; KHOURY H; FEARS C; DIPERSIO J
      G-CSF MOBILIZED GRANULOCYTE COMPONENTS TRANSFUSED INTO AUTOLOGOUS TRANSPLANT RECIPIENTS RESULTS IN SIGNIFICANT AND SUSTAINED ABSOLUTE NEUTROPHIL COUNT (ANC) INCREMENTS

      Blood
    28. TODD G; HAUG JS; BREMER R; LINK D; GOODNOUGH L; ADKINS D; BROWN R; DIPERSIO J
      STEADY-STATE CD14-LEVELS VARY ACCORDING TO SEX AND AGE(LINEAGE)

      Blood
    29. ADKINS D; SPITZER G; BROWN R; KHOURY H; GOODNOUGH T; TRIMBUR T; LIN H; DIPERSIO J
      LOW-INTENSITY CONDITIONING FOR RELATED DONOR ALLOGENEIC TRANSPLANT USING HIGH-DOSE-RATE LOW-DOSE (550 CGY) SINGLE EXPOSURE TOTAL-BODY IRRADIATION (TBI)

      Blood
    30. RICHART JM; MCINTYRE W; KLEBERT K; PETRUSKA P; ADKINS D; DUNPHY F; PINCUS S
      ADDITION OF ETOPOSIDE TO CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION AS A CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION DOES NOT IMPROVE DISEASE-FREE SURVIVAL IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES

      Blood
    31. GAJEWSKI J; WALL D; ADKINS D; GELLER R; YVER A; LLOYD K; SOUZA S; CHAMPLIN R
      A RANDOMIZED DOUBLE-BLIND TRIAL OF T-CELL DEPLETION WITH CD5 8 COLLECTOR(R) IN ADDITION TO CYCLOSPORINE, METHOTREXATE AND STEROIDS FOR ACUTE GRAFT-VERSUS-HOST DISEASE PREVENTION IN HLA MISMATCHED OR UNRELATED BONE-MARROW TRANSPLANT/

      Blood
    32. TODD G; HAUG JS; BREMER R; LINK D; GOODNOUGH L; ADKINS D; BROWN R; DIPERSIO J
      FLT3 LIGAND LEVELS VARY BEFORE AND DURING G-CSF MOBILIZATION

      Blood
    33. KHOURY H; ADKINS D; BROWN R; MILLER G; GOODNOUQH LT; DIPERSIO J
      TREATMENT OF HEPATIC VENOOCCLUSIVE DISEASE (VOD) WITH HIGH-DOSE CORTICOSTEROIDS - RESULTS IN 20 STEM-CELL TRANSPLANT RECIPIENTS

      Blood
    34. BROWN RA; ADKINS D; DIPERSIO J; GOODNOUGH T
      ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSC) IS ASSOCIATED WITH AN INCREASED RISK OF CHRONIC GRAFT-VS-HOST DISEASE

      Blood
    35. SHENOY S; BROWN R; ADKINS D; DIPERSIO J; MOHANAKUMAR T
      CONSTITUTIVE PERIPHERAL-BLOOD CYTOKINE M-RNA EXPRESSION IN GROWTH-FACTOR MOBILIZED NORMAL DONORS AND ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANT (PBSCT) RECIPIENTS

      Blood
    36. FREYTES CO; VUKELJA S; SALZMAN D; TSAI T; CALLANDER N; GOKMEN E; RODRIGUEZ T; CASTRO J; BOLDT D; ROODMAN GD; HILSENBECK S; ADKINS D; BACHIER C; CRAIG F; CLARE N; WEISNER A; LEMAISTRE CF
      AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR POOR-PROGNOSISLOW-GRADE LYMPHOMA

      Experimental hematology
    37. ADKINS D; SPITZER G; BROWN R; GOODNOUGH T; FADLER M; LIN H; DIPERSIO J
      HIGH-DOSE-RATE (30 CGY MIN) LOW-DOSE (550 CGY) SINGLE EXPOSURE TOTAL-BODY IRRADIATION (TBI) AS CONDITIONING FOR ALLOGENEIC PERIPHERAL-BLOODSTEM-CELL (ALLOPBSC) TRANSPLANTATION RESULTS IN COMPLETE DONOR CHIMERISM, AND RAPID ENGRAFTMENT WITHOUT SEVERE ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) OR TOXICITY/

      Blood
    38. GAJEWSKI J; WALL D; ADKINS D; GELLER R; YVER A; LLOYD K; SOUZA S; CHAMPLIN R
      A RANDOMIZED DOUBLE-BLIND TRIAL OF T-CELL DEPLETION (TCD) WITH CD5 8 CELLECTOR(R) IN ADDITION TO CYCLOSPORINE (CSA), METHOTREXATE (MTX) ANDSTEROIDS FOR ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) PREVENTION IN HLA MISMATCHED (MM) BONE MARRROW TRANSPLANTS (BMT)/

      Blood
    39. ADKINS D; GOODNOUGH T; BROWN R; DIPERSIO J
      BLOOD NEUTROPHIL RESPONSE TO G-CSF AND NUMBER OF NEUTROPHILS COLLECTED PER LEUKAPHERESIS (LA) PROCEDURE

      Blood
    40. ALI SM; DESPOTIS G; DYNIS M; ADKINS D; GOODNOUGH LT
      EVALUATION OF INTERFACE OFFSET IN FENWAL CS3000 ON GRANULOCYTE COLLECTION EFFICIENCY AND DONOR COUNTS

      Blood
    41. KHOURY H; ADKINS D; BROWN R; GOODNOUGH T; DIPERSIO J
      HIGH-DOSE CORTICOSTEROIDS FOR TREATMENT OF HEPATIC VENOOCCLUSIVE DISEASE (VOD) COMPLICATING STEM-CELL TRANSPLANTATION

      Blood
    42. DIPERSIO J; MARTIN B; ABBOUD CN; YARESHESKI J; ADKINS D; BROWN R
      INCREASED RATES OF CMV VIREMIA IN RECIPIENTS OF PERIPHERAL-BLOOD STEM-CELL (PBSC) ALLOGENEIC TRANSPLANTS - RATIONAL FOR BOTH PROPHYLACTIC THERAPY AND SHORT-COURSE SINGLE DAILY DOSING OF GANCICLOVIR FOR 21 DAYS

      Blood
    43. TODD G; HAUG JS; BROWN R; ADKINS D; DIPERSIO JF
      THE EFFECT OF G-CSF MOBILIZATION ON LYMPHOCYTE SUBSETS, MONOCYTES, NKCELLS, RBCS, PLATELETS, AND CD34+ LIN- PROGENITORS IN NORMAL ALLOGENEIC PBSC DONORS/

      Blood
    44. WOODSIDE J; ADKINS D
      PATIENT-CONTROLLED ANALGESIA IN FEMALES - INCREASED USE IN SMOKERS

      Journal of addictive diseases
    45. HEIMFELD S; THOMPSON P; LILES C; DALE D; BALDWIN G; ADKINS D; BERENSON R
      MAINTENANCE OF IN-VITRO GRANULOCYTE FUNCTION AFTER CRYOPRESERVATION

      Experimental hematology
    46. SPITZER G; ADKINS D; MCINTYRE W; DUNPHY F; VELASQUEZ M; BOWERS C; PETRUSKA P
      A RANDOMIZED STUDY SHOWING DELAYED EARLY PLATELET RECOVERY AFTER TANDEM PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANT WITH USE OF GROWTH-FACTORS (GFS) POST TRANSPLANT

      Blood
    47. BROWN RA; ADKINS D; GOODNOUGH T; WEHDE M; HENDRICKS D; EHLENBECK C; LAUB L; DIPERSIO J
      SEQUENTIAL INFUSION OF ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR CELLS (ALLOPBPC) CAN ELIMINATE PROFOUND NEUTROPENIA FOLLOWING TRANSPLANT

      Blood
    48. BROWN RA; ADKINS D; GOODNOUGH T; WEHDE M; HENDRICKS D; EHLENBECK C; LAUB L; DIPERSIO J
      ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANT DOES NOT APPEAR TO INCREASE THE RISK OF ACUTE GRAFT-VS-HOST DISEASE (GVHD) FOLLOWING HLA IDENTICAL SIBLING TRANSPLANT

      Blood
    49. ADKINS D; BORSON R; TABATABAI A; GOODNOUGH L; BROWN R; DIPERSIO J
      RAPID NEUTROPHIL AND PLATELET RECOVERY OCCURS AFTER HIGH-DOSE THERAPY(HDT) GIVEN WITHOUT POSTTRANSPLANT MYELOID GROWTH-FACTORS (GFS) WHEN INFUSED PERIPHERAL-BLOOD STEM-CELL (PBSC) PRODUCTS CONTAIN GREATER-THAN 2X10(6) CD34+ CELLS KG/

      Blood
    50. GOODNOUGH LT; BROWN R; ADKINS D; DIPERSIO J
      AN ANALYSIS OF ELDERLY (AGE GREATER-THAN-OR-EQUAL-TO-50 YEARS) ALLOGENEIC STEM-CELL PHERESIS DONORS

      Blood
    51. BROWN RA; ADKINS D; GOODNOUGH T; WEHDE M; HENDRICKS D; EHLENBECK C; LAUB L; DIPERSIO J
      THE LARGE MAJORITY OF NORMAL DONORS ONLY REQUIRE A SINGLE, 20 LITER PHERESIS PROCEDURE TO COLLECT ADEQUATE CELLS FOR ALLOGENEIC TRANSPLANT

      Blood
    52. ADKINS D; GOODGOLD H; HENDERSHOTT L; JOHNSTON M; CRAVENS D; SPITZER G
      INDIUM-LABELED WHITE BLOOD-CELLS (WBC) OBTAINED FROM BONE-MARROW DONORS RECEIVING GRANULOCYTE-COLONY-STIMULATING FACTOR (C-CSF) LOCALIZE TOSITES OF INFLAMMATION WHEN INFUSED INTO ALLOGENEIC BONE-MARROW TRANSPLANT (ALLO-BMT) RECIPIENTS

      Blood
    53. ADKINS D; JOHNSTON M; CRAVENS D; DUNPHY C; WALSH J; VELASQUEZ W; PETRUSKA P; BOWERS C; DUNPHY F; SPITZER G
      SIGNIFICANT PROLONGED INCREMENTS IN THE ABSOLUTE NEUTROPHIL COUNT (ANC) OF ALLOGENEIC BONE-MARROW TRANSPLANT (ALLO-BMT) RECIPIENTS (R) OCCURS WITH PROPHYLACTIC NEUTROPHIL INFUSIONS (INF) OBTAINED FROM HLA MATCHED DONORS (D) RECEIVING GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF)

      Blood
    54. TSAI T; GOODMAN S; SCHILLER G; ADKINS D; CALLANDER N; WOLFF S; FREYTES C
      ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO BMT) FOR RELAPSE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (AUTO BMT) IN LYMPHOMAS AND ACUTE-LEUKEMIA

      Blood
    55. TSAI T; SALZMAN D; CLARK G; CASTRO J; CALLANDER N; BOLDT D; ROODMAN GD; SHERIDANLEOS N; WIESNER A; ADKINS D; HARRIS K; RODRIGUEZ T; GOKMEN E; LEMAISTRE CF; FREYTES CO
      AUGMENTED CYCLOPHOSPHAMIDE (C), CARMUSTINE (B) AND ETOPOSIDE (V) + - DACARBAZINE (D) WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION (BMT) FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE - LOWER PERITRANSPLANT MORTALITY AND ANALYSIS OF PROGNOSTIC FACTORS/

      Blood
    56. ADKINS D; JOHNSTON M; GOODNOUGH L; CRAVENS D; WALSH J; SPITZER G
      HYDROXYETHYLSTARCH (HES) SEDIMENTATION (SED) IS INADEQUATE FOR RED-BLOOD-CELL (RBC) DEPLETION OF G-CSF PRIMED NEUTROPHIL PRODUCTS APHERESEDFROM HLA MATCHED BONE-MARROW (BM) DONORS, AND RESULTS IN SIGNIFICANT LOSS OF NEUTROPHIL AND PLATELET COMPONENTS

      Blood
    57. DANFORD DA; KUGLER JD; DEAL B; CASE C; FRIEDMAN RA; SAUL JP; SILKA MJ; VANHARE GF; ERICKSON C; CAMPBELL R; HULSE JE; WALSH E; KARPAWICH P; PERRY JC; ROSS B; BENSON DW; STERBA R; HORDOFF AJ; SCHAFFER MS; KANTER RJ; EPSTEIN M; COHEN M; KUEHL K; BEDER S; ADKINS D; MCCORMACK J; KURER C; WOLFF G; YOUNG ML; DICK M; BURTON D; GILLETTE PC; BROMBERG B; FENRICH AL; HAMILTON R; GOW R; FISH F
      THE LEARNING-CURVE FOR RADIOFREQUENCY ABLATION OF TACHYARRHYTHMIAS INPEDIATRIC-PATIENTS

      The American journal of cardiology
    58. ZIMMERMAN S; ADKINS D; GRAHAM M; PETRUSKA P; BOWERS C; VRAHNOS D; SPITZER G
      CASE-REPORT - IRREVERSIBLE, SEVERE CONGESTIVE CARDIOMYOPATHY OCCURRING IN ASSOCIATION WITH INTERFERON-ALPHA THERAPY

      Cancer biotherapy
    59. SPITZER G; MATHEWS M; DUNPHY F; BOWERS C; PETRUSKA P; VELASQUEZ W; BROUN G; KRONMUELLER N; NIEMEYER R; MCINTYRE W; ADKINS D
      ARE GROWTH-FACTOR (GF) COMBINATIONS SUPERIOR TO G-CSF ALONE FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS (PBSC) - A RANDOMIZED STUDY COMPARING G-CSF TO G-CSF WITH GM-CSF FOR PBSC MOBILIZATION

      Blood
    60. BOWERS C; ADKINS D; DUNPHY F; HARRISON B; LEMAISTRE CF; SPITZER G
      DOSE-ESCALATION OF MITOXANTRONE GIVEN WITH THIOTEPA AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR METASTATIC BREAST-CANCER

      Bone marrow transplantation
    61. ADKINS D; ENCARNACION C; SALZMAN D; BOLDT D; FREYTES C; VONHOFF DD; LEMAISTRE CF
      DURABLE COMPLETE REMISSION IN A PATIENT WITH REFRACTORY MEDIASTINAL NONSEMINOMATOUS GERM-CELL TUMOR AFTER TANDEM HIGH-DOSE CHEMOTHERAPY ANDAUTOLOGOUS BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    62. SPITZER G; ADKINS D; DUNPHY F; PETRUSKA P; SPENCER V; VELASQUEZ W
      DESIGN OF PREPARATIVE REGIMENS FOR STEM-CELL TRANSPLANTATION IN BREAST-CANCER

      Breast cancer research and treatment
    63. VELASQUEZ WS; DUNPHY F; SANTILLANA S; ADKINS D; BOWERS C; BROUN GO; PETRUSKA PJ; SPITZER G
      TANDEM HIGH-DOSE CHEMOTHERAPY REGIMENS IMPROVE DISEASE-FREE SURVIVAL IN PATIENTS WITH RELAPSING OF REFRACTORY HODGKINS (HD) AND NON-HODGKINS-LYMPHOMAS (NHL) - PRELIMINARY-REPORT

      Blood
    64. VELASQUEZ WS; DUNPHY F; SANTILLANA S; ADKINS D; BOWERS C; BROUN GO; PETRUSKA PJ; SPITZER G
      ASHAP, AN EFFECTIVE TREATMENT FOR RELAPSING AND REFRACTORY HODGKINS-DISEASE (HD) AND NON-HODGKINS-LYMPHOMA (NHL)

      Blood
    65. SPITZER G; SPENCER V; DUNPHY F; KULKARNI S; PETRUSKA P; VELASQUEZ W; BOWERS C; KRONMUELLER N; NIEMEYER R; MCINTYRE W; ADKINS D
      ARE GROWTH-FACTORS (GF) NEEDED AFTER PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION - A RANDOMIZED STUDY TO EVALUATE THE QUESTION

      Blood
    66. ADKINS D; BERENSON R; BOWERS C; BROUN G; DUNPHY F; KRONMUELLER N; PETRUSKA P; VELASQUEZ W; SPITZER G
      CD34-BLOOD STEM-CELLS (CPBSC) INFUSED AFTER HIGH-DOSE CHEMOTHERAPY (HDCT) RESULT IN EQUIVALENT HEMATOPOIETIC ENGRAFTMENT KINETICS AS COMPARED TO UNCONCENTRATED PBSC AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)( CONCENTRATED PERIPHERAL)

      Blood
    67. BOWERS C; ADKINS D; DUNPHY F; PETRUSKA P; VELASQUEZ W; MCINTYRE W; NIEMEYER R; RESTA D; SPITZER G
      SIMULTANEOUS INTERLEUKIN-3 (IL-3) AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) ADMINISTRATION AFTER HIGH-DOSE CHEMOTHERAPY(HDCT) IN PATIENTS WITH ADVANCED CANCER

      Blood
    68. RODRIQUEZ J; DUNPHY F; SPITZER G; VELAZQUEZ W; PETRUSKA P; ADKINS D; BOWERS C; BROUN G
      RANDOMIZED STUDY OF IN-VIVO GCSF (PRIMING) VS (NO PRIMING) BEFORE HIGH-DOSE THERAPY (HDT) WITH CYCLOPHOSPHAMIDE-ETOPOSIDE-CISPLATINUM (CVP)

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/01/21 alle ore 07:26:19